Skip to main content

Advertisement

Log in

ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank

  • Perspectives
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Cancer immunologists working in humans often require panels of tumour cell lines expressing different combinations of HLA alleles and other characteristics. Sources of cell lines are usually large cell banks carrying little immunologically relevant information on the available cells and limited numbers of different lines from the same type of tumour. Access to cells with desired combinations of characteristics is, therefore, difficult. Here, we describe an interactive database of a large collection of melanoma cell lines which have been extensively characterised for HLA genotype and surface expression, oncogene and tumour antigen expression, cytokine secretion, surface molecule expression, adhesion to extracellular matrix components, cytokine gene polymorphisms and other factors of interest to immunologists. This enables investigators to search for cells with particular constellations of HLA alleles, tumour antigens, etc., and then request these from the cell bank. This European Searchable Tumour Cell Line and Data Bank (ESTDAB) was established as a Research Infrastructure of the European Commission. For access to the databank and further details, please go to http://www.ebi.ac.uk/ipd/estdab/.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Halder T, Pawelec G, Kirkin AF, Zeuthen J, Meyer HE, Kun L, Kalbacher H (1997) Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res 57:3238–3244

    PubMed  CAS  Google Scholar 

  2. Li K, Adibzadeh M, Halder T, Kalbacher H, Heinzel S, Muller C, Zeuthen J, Pawelec G (1998) Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol Immunother 47:32–38

    Article  PubMed  CAS  Google Scholar 

  3. Stove C, Stove V, Derycke L, Van Marck V, Mareel M, Bracke M (2003) The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation. J Invest Dermatol 121:802–812

    Article  PubMed  CAS  Google Scholar 

  4. MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG (1999) Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83:555–563

    Article  PubMed  CAS  Google Scholar 

  5. Drexler HG, Matsuo Y, MacLeod RA (2003) Persistent use of false myeloma cell lines. Hum Cell 16:101–105

    Article  PubMed  Google Scholar 

  6. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65:9328–9337

    Article  PubMed  CAS  Google Scholar 

  7. Mestas J, Hughes CCW (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738

    PubMed  CAS  Google Scholar 

  8. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104–107

    Article  PubMed  CAS  Google Scholar 

  9. Rodriguez T, Mendez R, Roberts CH, Ruiz-Cabello F, Dodi IA, Lopez Nevot MA, Paco L, Maleno I, Marsh SG, Pawelec G, Garrido F (2005) High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunol Immunother 54:141–148

    Article  PubMed  CAS  Google Scholar 

  10. Laidler P, Litynska A, Hoja-Lukowicz D, Labedz M, Przybylo M, Ciolczyk-Wierzbicka D, Pochec E, Trebacz E, Kremser E (2005) Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol Immunother DOI:10.1007/s00262-005-0019-4 [Epub ahead of print]

Download references

Acknowledgements

The establishment of database and cell bank was supported by the European Commission (contract # QLRI-CT-2001-01325). Some of the work characterising the cells was also supported by EC contracts # QLG1-CT-2002-00668 (OISTER) and 6FP-CT-503306 (ENACT).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Graham Pawelec.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pawelec, G., Marsh, S.G. ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. Cancer Immunol Immunother 55, 623–627 (2006). https://doi.org/10.1007/s00262-005-0117-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-005-0117-3

Keywords

Navigation